1888 related articles for article (PubMed ID: 26628643)
1. Rationally engineered Cas9 nucleases with improved specificity.
Slaymaker IM; Gao L; Zetsche B; Scott DA; Yan WX; Zhang F
Science; 2016 Jan; 351(6268):84-8. PubMed ID: 26628643
[TBL] [Abstract][Full Text] [Related]
2. Structural Basis for the Altered PAM Specificities of Engineered CRISPR-Cas9.
Hirano S; Nishimasu H; Ishitani R; Nureki O
Mol Cell; 2016 Mar; 61(6):886-94. PubMed ID: 26990991
[TBL] [Abstract][Full Text] [Related]
3. Engineered CRISPR-Cas9 nucleases with altered PAM specificities.
Kleinstiver BP; Prew MS; Tsai SQ; Topkar VV; Nguyen NT; Zheng Z; Gonzales AP; Li Z; Peterson RT; Yeh JR; Aryee MJ; Joung JK
Nature; 2015 Jul; 523(7561):481-5. PubMed ID: 26098369
[TBL] [Abstract][Full Text] [Related]
4. Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases.
Cho SW; Kim S; Kim Y; Kweon J; Kim HS; Bae S; Kim JS
Genome Res; 2014 Jan; 24(1):132-41. PubMed ID: 24253446
[TBL] [Abstract][Full Text] [Related]
5. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
[TBL] [Abstract][Full Text] [Related]
6. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
7. Probing the structural dynamics of the CRISPR-Cas9 RNA-guided DNA-cleavage system by coarse-grained modeling.
Zheng W
Proteins; 2017 Feb; 85(2):342-353. PubMed ID: 27936513
[TBL] [Abstract][Full Text] [Related]
8. Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.
Chen JS; Dagdas YS; Kleinstiver BP; Welch MM; Sousa AA; Harrington LB; Sternberg SH; Joung JK; Yildiz A; Doudna JA
Nature; 2017 Oct; 550(7676):407-410. PubMed ID: 28931002
[TBL] [Abstract][Full Text] [Related]
9. Crossing enhanced and high fidelity SpCas9 nucleases to optimize specificity and cleavage.
Kulcsár PI; Tálas A; Huszár K; Ligeti Z; Tóth E; Weinhardt N; Fodor E; Welker E
Genome Biol; 2017 Oct; 18(1):190. PubMed ID: 28985763
[TBL] [Abstract][Full Text] [Related]
10. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.
Kleinstiver BP; Pattanayak V; Prew MS; Tsai SQ; Nguyen NT; Zheng Z; Joung JK
Nature; 2016 Jan; 529(7587):490-5. PubMed ID: 26735016
[TBL] [Abstract][Full Text] [Related]
11. Cas9-catalyzed DNA Cleavage Generates Staggered Ends: Evidence from Molecular Dynamics Simulations.
Zuo Z; Liu J
Sci Rep; 2016 Nov; 5():37584. PubMed ID: 27874072
[TBL] [Abstract][Full Text] [Related]
12. Structural Plasticity of PAM Recognition by Engineered Variants of the RNA-Guided Endonuclease Cas9.
Anders C; Bargsten K; Jinek M
Mol Cell; 2016 Mar; 61(6):895-902. PubMed ID: 26990992
[TBL] [Abstract][Full Text] [Related]
13. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.
Cho SW; Kim S; Kim JM; Kim JS
Nat Biotechnol; 2013 Mar; 31(3):230-2. PubMed ID: 23360966
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Reconstitution and Crystallization of Cas9 Endonuclease Bound to a Guide RNA and a DNA Target.
Anders C; Niewoehner O; Jinek M
Methods Enzymol; 2015; 558():515-537. PubMed ID: 26068752
[TBL] [Abstract][Full Text] [Related]
15. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation.
Jinek M; Jiang F; Taylor DW; Sternberg SH; Kaya E; Ma E; Anders C; Hauer M; Zhou K; Lin S; Kaplan M; Iavarone AT; Charpentier E; Nogales E; Doudna JA
Science; 2014 Mar; 343(6176):1247997. PubMed ID: 24505130
[TBL] [Abstract][Full Text] [Related]
16. STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition.
Jiang F; Zhou K; Ma L; Gressel S; Doudna JA
Science; 2015 Jun; 348(6242):1477-81. PubMed ID: 26113724
[TBL] [Abstract][Full Text] [Related]
17. In vitro enzymology of Cas9.
Anders C; Jinek M
Methods Enzymol; 2014; 546():1-20. PubMed ID: 25398333
[TBL] [Abstract][Full Text] [Related]
18. Structures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage.
Jiang F; Taylor DW; Chen JS; Kornfeld JE; Zhou K; Thompson AJ; Nogales E; Doudna JA
Science; 2016 Feb; 351(6275):867-71. PubMed ID: 26841432
[TBL] [Abstract][Full Text] [Related]
19. Conformational control of DNA target cleavage by CRISPR-Cas9.
Sternberg SH; LaFrance B; Kaplan M; Doudna JA
Nature; 2015 Nov; 527(7576):110-3. PubMed ID: 26524520
[TBL] [Abstract][Full Text] [Related]
20. Shortening the sgRNA-DNA interface enables SpCas9 and eSpCas9(1.1) to nick the target DNA strand.
Fan R; Chai Z; Xing S; Chen K; Qiu F; Chai T; Qiu JL; Zhang Z; Zhang H; Gao C
Sci China Life Sci; 2020 Nov; 63(11):1619-1630. PubMed ID: 32592086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
